Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDuliba, Katherine A.-
dc.contributor.authorKauffman, Robert J.-
dc.date.accessioned2006-02-02T15:19:19Z-
dc.date.available2006-02-02T15:19:19Z-
dc.date.issued1993-09-03-
dc.identifier.urihttp://hdl.handle.net/2451/14271-
dc.description.abstractThis chapter presents an edited transcript of an interview held in August 1993 with Brian Slater, a vice-president in the Global Bank at Chemical Bank. Slater is responsible for the firm's U.S.-based trading and global risk management systems. The interview was conducted in the context of Project 1990s -- the U.S. Council for International Banking's Study on Information Technology Investment and International Banking Performance. The purpose of the discussion was to develop background information on the issues the bank's senior management team faced in merging the trading and treasury functions of Chemical Bank and Manufacturers Hanover Trust. The new Global Bank faces challenges in the areas of global risk management, cost-effective delivery of in formation technology-based products, trading infrastructure application functionality gaps, and human resource management that can be best addressed by a shift to a new paradigm for trading and treasury application software development: reuse of object-oriented representations of the bank's systems. We now turn to the details of the discussion that develops these themes.en
dc.format.extent3594641 bytes-
dc.format.mimetypeapplication/pdf-
dc.languageEnglishEN
dc.language.isoen_US-
dc.publisherStern School of Business, New York Universityen
dc.relation.ispartofseriesIS-93-38-
dc.titleRE-ARCHITECTING AND RE-ENGINEERING TRADING AND TREASURY SYSTEMS IN THE MERGER OF CHEMICAL BANK AND MANUFACTURERS HANOVER TRUST -- An Interview with Brian Slater, Vice-President, Chemical Banken
dc.typeWorking Paperen
dc.description.seriesInformation Systems Working Papers SeriesEN
Appears in Collections:IOMS: Information Systems Working Papers

Files in This Item:
File Description SizeFormat 
IS-93-38.pdf3.51 MBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.